UH to launch study to protect clinicians against COVID-19

University Hospitals Logo

University Hospitals will lead a clinical trial of an investigational drug manufactured by a Cleveland company to assess whether it helps prevent airborne transmission of coronavirus and whether it reduces the symptoms of health care providers who have tested positive for COVID-19.

The Cleveland Foundation has authorized $1 million in emergency funding to support a significant portion of the clinical trial from previously restricted health-related research grant dollars at the foundation, according to a news release.

Click here to read the complete story.

Story excerpt provided by Crains Cleveland Business.

Written by Lydia Coutre.

Originally published April 2, 2020.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: